Stiftelsen
Gävle Cancerfond

Publikationer

Artiklar som producerats med bidrag helt eller delvis via bidrag från Stiftelsen Gävle Cancerfond

  1. Molecular Profiling Using Tissue Microarrays as a Tool to Identify Predicitve Biomarkers in Laryngeal Cancer Treated With Radiotherapy. G Holgersson, S Ekman, J Reizenstein, M Bergqvist, F Ponte´n, M Uhle´n, K Magnusson, P Jonnalagadda, A Asplund, S Strömberg, A Linder, E Blomquist, M Liljeholm, B Löde´n, K Hellström and S Bergström. Cancer Genomics & Proteomics 7(1): 1-8 (2010).

  2. Dual headed coincidence PET vs. dedicated PET/CT in the evaluation of lung cancer and lymphomas. S Bergström, G Holgersson, J-E Bergqvist, M Bergqvist, S Ekman and M Stenström. In Vivo, 24: 235-238 (2010)

  3. Mast cells in squamous cell esophageal carcinoma and clinical parameters. B Tinge, D Molin, M Bergqvist, S Ekman, R-M Amini, P Hesselius and S Bergström. Cancer Genomics & Proteomics 7(1): 25-30 (2010).

  4. Swedish Lung Cancer Radiation Study Group: Predictive value of histology for radiotherapy response in patients with non-small cell lung cancer. G Holgersson, S Bergström, M Bergqvist, J Nyman, E Hoye, M Helsing, S Friesland, M Holgersson, E Birath S Ekman, T Blystad, S-E Ewers, C Mörth, B Löden, and R Henriksson. Eur J Cancer 47(16): 2415-2421 (2011)

  5. Swedish Lung Cancer Radiation Study Group: Predictive value of age at diagnosis for radiotherapy response in patients with non-small cell lung cancer. G Holgersson, E Hoye, M Bergqvist, S Ekman, J Nyman, M Helsing, S Friesland, M Holgersson, L Ekberg, T Blystad, S-E Ewers, C Mörth, B Löden, R Henriksson and S Bergström. Acta Oncol 51(6): 759-767 (2012)

  6. The value of induction chemotherapy for survival in patients with non-small cell lung cancer treated with radiotherapy. G Holgersson, M Sandelin, E Hoye, S Bergström , R Henriksson, S Ekman, J Nyman, M Helsing, S Friesland, O Brodin, M Holgersson, KL Lundström, Janson C, L Ekberg, C Mörth, T Blystad, S-E Ewers, B Löden and M Bergqvist Anticancer Res 32(4): 1339-1346 (2012)

  7. Swedish Lung Cancer Radiation Study Group: the prognostic value of anaemia, thrombocytosis and leukocytosis at time of diagnosis in patients with non-small cell lung cancer. G Holgersson, M Sandelin, E Hoye, S Bergström, R Henriksson, S Ekman, J Nyman, M Helsing, S Friesland, M Holgersson, KL Lundström, C Janson, E Birath, C Mörth, T Blystad, S-E Ewers, B Löden, and M Bergqvist. Med Oncol 29(5): 3176-3182 (2012)

  8. Microtubule inhibition causes epidermal growth factor receptor inactivation in oesophageal cancer cells. X Wu, L Sooman, J Lennartsson, S Bergström, M Bergqvist, J Gullbo and S Ekman. Int J Oncol 42(1): 297-304 (2013)

  9. The impact of hyperfractionated radiotherapy regimen in patients with non-small cell lung cancer. G Holgersson, M Bergqvist, J Nyman, E Hoye, M Helsing, S Friesland, M Holgersson, L Ekberg, C Mörth, S Ekman, T Blystad, S-E Ewers, B Löden, R Henriksson and S Bergström. Med Oncol 30(1): 320 (2013) Epub 2012

  10. Driving for patients in palliative care-a reality. A Widman and S Bergström (SpringerPlus 2014, 3:79)

  11. Effect of increased radiotoxicity on survival of patients with non-small lung cancer treated with curatively intended radiotherapy. G Holgersson, S Bergström, P Liv, J Nilsson, P Edlund, C Blomberg, J Nyman, S Friesland, S Ekman, T Asklund, R Henriksson and M Bergqvist. Anticancer Res 35 (10);5491-5497 (2015)

  12. The Prognostic Value of Pre-treatment Thrombocytosis in Two Cohorts of Patients with Non-small Cell Lung Cancer Treated with Curatively Intended Chemoradiotherapy G Holgerson, S Bergström, A Hallqvist, P Liv, J Nilsson, C Blomberg, L Willén, J Nyman, S Ekman, R Henriksson, M Bergqvist. Neoplasma, 64(6); 909-915 (2017)

  13. The role of income in brain tumor patients: a descriptive register-based study. Nilsson J, Holgersson G, Järås J, Bergström S and Bergqvist M. Medical Oncology 13; 35(4):52 (2018)

  14. No evidence for increased brain tumour incidence in the Swedish national cancer register between year 1980-2012. Nilsson J, Järås J, Henriksson R, Holgersson G, Bergström S, Estenberg J, Augustsson T and Bergqvist M. Anticancer Res 39(2):791-796 (2019)

  15. Educational level and management and outcomes in non-small cell lung cancer. A nationwide population-based study. Willén L, Berglund A, Bergström S, Bergqvist M, Öjdahl-Bodén A, Wagenius G and Lambe M. Lung cancer 131:40-46 (2019)

  16. Geographical differences in likelihood of home death among palliative care patients: a national population-based register study. Nilsson J, Axelsson B, Holgersson G, Carlsson T, Bergqvist M and Bergström S. Anticancer Research 40: 3897-3903 (2020)

  17. Socioeconomy as a prognostic factor for location of death in Swedish palliative care patients. Nilsson J, Holgersson G, Ullenhag G, Holmgren M, Axelsson B, Carlsson T, Bergqvist M and Bergström S. BMC Palliative Care 20:43, 1-7 (2021)

  18. Are older patients with non-small cell lung cancer receiving optimal care? A population-based study. Willén L, Berglund A, Bergström S, Isaksson J, Bergqvist M, Wagenius G, Lambe M. Acta Oncol 61(3): 309-317 (2022)

  19. Reply to Assoc Prof. Kocak. Willén L, Berglund A, Bergström S, Isaksson J, Bergqvist M, Wagenius G, Lambe M. Acta Oncol 61(3): 320 (2022)

  20. Patterns of care and outcomes in immigrants with non-small cell lung cancer. A population-based study (Sweden). Willén L, Berglund A, Bergström S, Isaksson J, Bergqvist M, Wagenius G, Lambe M. PLOS One 2022

  21. Use of CAM among cancer patients. Results of a regional survey in Sweden
    Källman M, Bergström S, Carlsson T, Järås J, Holgersson G,
    Hök Nordberg J, Nilsson J, Wode K, Bergqvist M. BMC Complementary Medicine and Therapies 23:51(2023)

  22. Prospective Study of Preferred Versus Actual Place of Death Among Swedish Palliative
    Cancer Patients. Nilsson J, Bergström S, Hållberg H, Berglund A, Bergqvist M, and Holgersson G. American Journal of Hospice & Palliative Medicine Vol 0(0), 1-9 (2023)

  23. Association between obstructive sleep apnoea and cancer: a cross-sectional, population-based study of the DISCOVERY cohort. Palm A, Theorell-Haglöw J, Isakson J, Ljunggren M, Sundh J, Ekström MP, Grote L. BMJ Open. 2023 Mar 3;13(3)

Reviews:

  1. Randomized trials of systemic medically-tretaed malignant mesothelioma.. A sytematic review. C Blomberg, J Nilsson, G Holgersson, P Edlund, M Bergqvist, L Adwall, S Ekman, D Brattström and S Bergström. Anticancer Res. 35(5);2493-2501. (2015)

  2. The use of complementary and alternative medicine in Scandinavia. J Nilsson, M Källman, U Östlund, G Holgersson, M Bergqvist, S Bergström. Anticancer Res 36(7);3243-3251 (2016)

  3. Incidence rates in low-grade primary brain tumors-are there differences between men and women? Nilsson J, Holgersson G, Carlsson T, Henriksson R, Bergstrom S and Bergqvist M
    A systematic review. World Journal of Oncology. 7(4);59-69 (2016)

  4. Incidence trends in high grade primary brain tumors in men and women. A systematic review. Nilsson J, Holgersson G, Carlsson T, Henriksson R, Bergström S and Bergqvist M. Oncology Letters 13(4); 2831-2837 (2017)

  5. End-of-life care: Where do cancer patients want to die? A systematic review. J Nilsson, C Blomberg, G Holgersson, T Carlsson, M Bergqvist and S Bergström. Asia-Pac J Clin Oncol 13(6); 356-364 (2017).